Effects of cyclophosphamide and IL-2 on regulatory CD4+ T cell frequency and function in melanoma patients vaccinated with HLA-class I peptides: impact on the antigen-specific T cell response.
about
Targeting Immune Regulatory Networks to Counteract Immune Suppression in CancerEffects of programmed death-ligand 1 expression on OK-432 immunotherapy following transurethral resection in non-muscle invasive bladder cancerTrial watch: Immunostimulatory cytokines in cancer therapy.Dissecting the regulatory microenvironment of a large animal model of non-Hodgkin lymphoma: evidence of a negative prognostic impact of FOXP3+ T cells in canine B cell lymphoma.Classification of current anticancer immunotherapiesInterleukin-2 administration after modified radical mastectomy in breast cancer therapy increases peripheral regulatory T cells.Recent progress in peptide vaccination in cancer with a focus on non-small-cell lung cancer.What is the role of chemotherapy in the treatment of melanoma?The importance of correctly timing cancer immunotherapy.Scrutinizing calcium flux oscillations in T lymphocytes to deduce the strength of stimulus.Human OX40 tunes the function of regulatory T cells in tumor and nontumor areas of hepatitis C virus-infected liver tissue.Convergences and divergences of thymus- and peripherally derived regulatory T cells in cancerA phase I clinical trial of RNF43 peptide-related immune cell therapy combined with low-dose cyclophosphamide in patients with advanced solid tumors.T cell modulation by cyclophosphamide for tumour therapy.Human regulatory T cells lack the cyclophosphamide-extruding transporter ABCB1 and are more susceptible to cyclophosphamide-induced apoptosis.Regulatory T Cells As Potential Targets for HIV Cure Research.Trial Watch: Chemotherapy with immunogenic cell death inducers.
P2860
Q28066486-DFE9B228-E6C8-491C-A28F-9AB596C5535CQ33751253-F6FE46C2-64C9-4FDE-BDAB-8D8041ADF934Q33880165-45965443-CD38-4EDD-B80E-DFFC96AA980BQ34041661-179AC0BC-77C6-460C-A281-84B9C5DE739BQ35149637-A8803941-34A0-45E2-957D-9656732458FEQ35870925-ABC13981-2289-4D8D-BF7D-CA82EECF078AQ38168904-B6D0A0FA-9080-43E9-903E-0893D2621D26Q38193716-C4C2478B-DB3B-442B-B472-BDB3FE8F5AA5Q38995979-3775DA4A-3B9C-49D6-8331-1B3A1D90C05FQ42068364-3D862E22-5C52-4ECF-A1A7-48D8845A080DQ42222888-205129E9-A1C0-439D-805A-D39AA0A03BCEQ42571627-F0C78810-40C4-475B-9597-D73E5722F6B5Q47238978-8856C13F-54CE-4799-A3B1-9B7FFD3035BFQ49822317-0A7A690D-2CC8-4BBD-A5E7-8EE081FCD1ABQ50449094-85931622-7232-4F12-B17B-97505073C437Q52715799-27644EF5-B072-49CF-B893-71EACB5DEBB3Q55260834-A5094193-B5E7-4A18-835A-B89AB473C8C9
P2860
Effects of cyclophosphamide and IL-2 on regulatory CD4+ T cell frequency and function in melanoma patients vaccinated with HLA-class I peptides: impact on the antigen-specific T cell response.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Effects of cyclophosphamide an ...... igen-specific T cell response.
@ast
Effects of cyclophosphamide an ...... igen-specific T cell response.
@en
type
label
Effects of cyclophosphamide an ...... igen-specific T cell response.
@ast
Effects of cyclophosphamide an ...... igen-specific T cell response.
@en
prefLabel
Effects of cyclophosphamide an ...... igen-specific T cell response.
@ast
Effects of cyclophosphamide an ...... igen-specific T cell response.
@en
P2093
P2860
P50
P1476
Effects of cyclophosphamide an ...... igen-specific T cell response.
@en
P2093
Agata Cova
Antonello Villa
Barbara Vergani
Chiara Casati
Gabrina Tragni
Giorgio Parmiani
Lorenzo Pilla
Ludmila Umansky
Paola Filipazzi
Philipp Beckhove
P2860
P2888
P304
P356
10.1007/S00262-013-1397-7
P50
P577
2013-04-16T00:00:00Z